Vistagen Therapeutics, Inc. (VTGN)

0.7279 +0.01 (+2.08%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Vistagen Therapeutics Cash and Short Term Investments (Annual): 80.48M for March 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for VTGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. 374.64M
XOMA Royalty Corp. 106.51M
Omeros Corp. 90.13M
GeoVax Labs, Inc. 5.507M
Daré Bioscience, Inc. 15.70M